1 the efficacy of the converting-enzyme inhibitor captopril in the management of severe congestive heart failure was assessed in 14 patients over 360-885 days by clinical evaluation , m-mode echocardiography , systolic time intervals , plasma renin activity , and plasma aldosterone .
C0006938
captopril
C0018802
congestive heart failure